Activation of the dsRNA-activated protein kinase PKR in mitochondrial dysfunction and inflammatory stress in metabolic syndrome

Neetu Sud, Angela C. Rutledge, Kaichao Pan, Qiaozhu Su

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The double stranded RNA (dsRNA)-activated protein kinase PKR is a well-established protein kinase that is activated by dsRNA during viral infection, and it inhibits global protein synthesis by phosphorylating the alpha subunit of eukaryotic initiation factor 2α (eIF2α). Recent studies have greatly broadened the recognized physiological activities of PKR by demonstrating its fundamental role in inflammatory signaling, particularly in chronic, low-grade inflammation induced by metabolic disorders, known as metaflammation. Metaflammation is initiated by the activation of the NOD-like receptor (NLR), leucine-rich repeat, pyrin domaincontaining 3 (NLRP3) gene by mitochondrial reactive oxygen species (ROS). A protein complex defined as the metaflammasome is assembled in the course of metaflammation. This complex integrates nutritional signaling with cellular stress, inflammatory components, and insulin action and is essential in maintaining metabolic homeostasis. PKR is a key constituent of the metaflammasome and interacts directly with several inflammatory kinases, such as inhibitor κB (IκB) kinase (IKK) and c-Jun N-terminal kinase (JNK), insulin receptor substrate 1 (IRS1), and component of the translational machinery such as eIF2α. Conclusion: This review highlights recent findings in PKR-mediated metaflammation and its association with the onset of metabolic syndrome in both human and animal models, with a focus on the molecular and biochemical pathways that underlie the progression of obesity, insulin resistance, and type-2 diabetes.

Original languageEnglish (US)
Pages (from-to)2697-2703
Number of pages7
JournalCurrent Pharmaceutical Design
Volume22
Issue number18
DOIs
StatePublished - May 1 2016

Fingerprint

Eukaryotic Initiation Factor-2
eIF-2 Kinase
Double-Stranded RNA
Phosphotransferases
Insulin Receptor Substrate Proteins
Mitochondrial Genes
JNK Mitogen-Activated Protein Kinases
Virus Diseases
Leucine
Protein Kinases
Type 2 Diabetes Mellitus
Insulin Resistance
Reactive Oxygen Species
Proteins
Homeostasis
Animal Models
Obesity
Insulin
Inflammation

Keywords

  • ER stress
  • Metabolic diseases
  • Metaflammation
  • Mitochondrial dysfunction
  • dsRNA-Activated Protein Kinase PKR

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Activation of the dsRNA-activated protein kinase PKR in mitochondrial dysfunction and inflammatory stress in metabolic syndrome. / Sud, Neetu; Rutledge, Angela C.; Pan, Kaichao; Su, Qiaozhu.

In: Current Pharmaceutical Design, Vol. 22, No. 18, 01.05.2016, p. 2697-2703.

Research output: Contribution to journalArticle

@article{1caebda767df4c83802730e153f0ff65,
title = "Activation of the dsRNA-activated protein kinase PKR in mitochondrial dysfunction and inflammatory stress in metabolic syndrome",
abstract = "Background: The double stranded RNA (dsRNA)-activated protein kinase PKR is a well-established protein kinase that is activated by dsRNA during viral infection, and it inhibits global protein synthesis by phosphorylating the alpha subunit of eukaryotic initiation factor 2α (eIF2α). Recent studies have greatly broadened the recognized physiological activities of PKR by demonstrating its fundamental role in inflammatory signaling, particularly in chronic, low-grade inflammation induced by metabolic disorders, known as metaflammation. Metaflammation is initiated by the activation of the NOD-like receptor (NLR), leucine-rich repeat, pyrin domaincontaining 3 (NLRP3) gene by mitochondrial reactive oxygen species (ROS). A protein complex defined as the metaflammasome is assembled in the course of metaflammation. This complex integrates nutritional signaling with cellular stress, inflammatory components, and insulin action and is essential in maintaining metabolic homeostasis. PKR is a key constituent of the metaflammasome and interacts directly with several inflammatory kinases, such as inhibitor κB (IκB) kinase (IKK) and c-Jun N-terminal kinase (JNK), insulin receptor substrate 1 (IRS1), and component of the translational machinery such as eIF2α. Conclusion: This review highlights recent findings in PKR-mediated metaflammation and its association with the onset of metabolic syndrome in both human and animal models, with a focus on the molecular and biochemical pathways that underlie the progression of obesity, insulin resistance, and type-2 diabetes.",
keywords = "ER stress, Metabolic diseases, Metaflammation, Mitochondrial dysfunction, dsRNA-Activated Protein Kinase PKR",
author = "Neetu Sud and Rutledge, {Angela C.} and Kaichao Pan and Qiaozhu Su",
year = "2016",
month = "5",
day = "1",
doi = "10.2174/1381612822666160202141845",
language = "English (US)",
volume = "22",
pages = "2697--2703",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "18",

}

TY - JOUR

T1 - Activation of the dsRNA-activated protein kinase PKR in mitochondrial dysfunction and inflammatory stress in metabolic syndrome

AU - Sud, Neetu

AU - Rutledge, Angela C.

AU - Pan, Kaichao

AU - Su, Qiaozhu

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Background: The double stranded RNA (dsRNA)-activated protein kinase PKR is a well-established protein kinase that is activated by dsRNA during viral infection, and it inhibits global protein synthesis by phosphorylating the alpha subunit of eukaryotic initiation factor 2α (eIF2α). Recent studies have greatly broadened the recognized physiological activities of PKR by demonstrating its fundamental role in inflammatory signaling, particularly in chronic, low-grade inflammation induced by metabolic disorders, known as metaflammation. Metaflammation is initiated by the activation of the NOD-like receptor (NLR), leucine-rich repeat, pyrin domaincontaining 3 (NLRP3) gene by mitochondrial reactive oxygen species (ROS). A protein complex defined as the metaflammasome is assembled in the course of metaflammation. This complex integrates nutritional signaling with cellular stress, inflammatory components, and insulin action and is essential in maintaining metabolic homeostasis. PKR is a key constituent of the metaflammasome and interacts directly with several inflammatory kinases, such as inhibitor κB (IκB) kinase (IKK) and c-Jun N-terminal kinase (JNK), insulin receptor substrate 1 (IRS1), and component of the translational machinery such as eIF2α. Conclusion: This review highlights recent findings in PKR-mediated metaflammation and its association with the onset of metabolic syndrome in both human and animal models, with a focus on the molecular and biochemical pathways that underlie the progression of obesity, insulin resistance, and type-2 diabetes.

AB - Background: The double stranded RNA (dsRNA)-activated protein kinase PKR is a well-established protein kinase that is activated by dsRNA during viral infection, and it inhibits global protein synthesis by phosphorylating the alpha subunit of eukaryotic initiation factor 2α (eIF2α). Recent studies have greatly broadened the recognized physiological activities of PKR by demonstrating its fundamental role in inflammatory signaling, particularly in chronic, low-grade inflammation induced by metabolic disorders, known as metaflammation. Metaflammation is initiated by the activation of the NOD-like receptor (NLR), leucine-rich repeat, pyrin domaincontaining 3 (NLRP3) gene by mitochondrial reactive oxygen species (ROS). A protein complex defined as the metaflammasome is assembled in the course of metaflammation. This complex integrates nutritional signaling with cellular stress, inflammatory components, and insulin action and is essential in maintaining metabolic homeostasis. PKR is a key constituent of the metaflammasome and interacts directly with several inflammatory kinases, such as inhibitor κB (IκB) kinase (IKK) and c-Jun N-terminal kinase (JNK), insulin receptor substrate 1 (IRS1), and component of the translational machinery such as eIF2α. Conclusion: This review highlights recent findings in PKR-mediated metaflammation and its association with the onset of metabolic syndrome in both human and animal models, with a focus on the molecular and biochemical pathways that underlie the progression of obesity, insulin resistance, and type-2 diabetes.

KW - ER stress

KW - Metabolic diseases

KW - Metaflammation

KW - Mitochondrial dysfunction

KW - dsRNA-Activated Protein Kinase PKR

UR - http://www.scopus.com/inward/record.url?scp=84974710810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974710810&partnerID=8YFLogxK

U2 - 10.2174/1381612822666160202141845

DO - 10.2174/1381612822666160202141845

M3 - Article

C2 - 26831644

AN - SCOPUS:84974710810

VL - 22

SP - 2697

EP - 2703

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 18

ER -